Two-Year Clinical Outcomes of the PAUL® Glaucoma Implant in White Patients with Refractory Glaucoma

Constance Weber,Sarah Hundertmark,Isabel Stasik,Frank G. Holz,Karl Mercieca

DOI: https://doi.org/10.1097/ijg.0000000000002457

2024-07-01

Journal of Glaucoma

Abstract:Précis: This prospectively collected case series of 56 eyes having PAUL glaucoma implant surgery is the first to demonstrate its medium term safety and effectiveness in what is essentially an exclusively Caucasian population. Background: To report two-year outcomes from a single-center cohort undergoing PAUL® Glaucoma Implant (PGI) surgery. Methods: Prospectively collected data of patients undergoing PGI surgery at the University Eye Hospital Bonn, Germany, from 04/2021 to 09/2021. Results: 56 eyes of 53 patients were included. Complete and qualified success rates (95% CI) were 52% (37–66) and 89% (80–96) for Criterion A (IOP≤21 mm Hg), 48% (36–61) and 79% (67–88) for Criterion B (IOP≤18 mm Hg), 45% (32–57) and 64% (52–77%) for Criterion C (IOP≤15 mm Hg) and 27% (16–40) and 38% (25–50) for Criterion D (IOP≤12 mm Hg) respectively. Mean IOP decreased from 25.43 mm Hg (7–48 mm Hg) to 11.25 mm Hg (3–24 mm Hg) (reduction of 50%) after 24 months with a reduction of IOP-lowering agents from 3.50 (1–5) to 0.46 (0–3). One eye needed an injection of viscoelastic due to significant hypotony with AC shallowing; 3 eyes received a DMEK due to persistent corneal decompensation; 9 eyes developed tube exposure which required conjunctival revision with additional pericardial patch graft, with 5 of these eyes eventually needing tube explantation. An intraluminal prolene stent was removed in 24 eyes (42.9%) after a mean time period of 5.67 months (2–15 m). Mean IOP before removal was 21.4 mm Hg (12–40 mm Hg) and decreased to 11.15 mm Hg (6–20 mm Hg). Conclusions: PGI surgery is an effective procedure for reducing IOP and pressure-lowering therapy. The use of an intraluminal prolene stent impedes hypotony in the early postoperative phase and enables further non-invasive IOP lowering during the postoperative course.

ophthalmology